Annual FCF
$14.37 M
+$37.20 M+162.95%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual free cash flow is $14.37 million, with the most recent change of +$37.20 million (+162.95%) on December 31, 2023.
- During the last 3 years, PBYI annual FCF has risen by +$23.64 million (+254.96%).
- PBYI annual FCF is now -34.89% below its all-time high of $22.07 million, reached on December 31, 2019.
Performance
PBYI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$11.02 M
+$10.01 M+994.14%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly free cash flow is $11.02 million, with the most recent change of +$10.01 million (+994.14%) on September 30, 2024.
- Over the past year, PBYI quarterly FCF has increased by +$430.00 thousand (+4.06%).
- PBYI quarterly FCF is now -75.10% below its all-time high of $44.25 million, reached on June 30, 2019.
Performance
PBYI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$33.68 M
+$430.00 K+1.29%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM free cash flow is $33.68 million, with the most recent change of +$430.00 thousand (+1.29%) on September 30, 2024.
- Over the past year, PBYI TTM FCF has increased by +$22.04 million (+189.31%).
- PBYI TTM FCF is now -5.05% below its all-time high of $35.47 million, reached on March 31, 2024.
Performance
PBYI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PBYI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +162.9% | +4.1% | +189.3% |
| 3 y3 years | +255.0% | +179.4% | +194.3% |
| 5 y5 years | +158.1% | +179.4% | +194.3% |
PBYI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | +162.9% | -36.2% | +141.0% | -5.0% | +194.3% |
| 5 y | 5-year | -34.9% | +162.9% | -36.2% | +141.0% | -5.0% | +194.3% |
| alltime | all time | -34.9% | +106.5% | -75.1% | +112.8% | -5.0% | +115.1% |
Puma Biotechnology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $11.02 M(+994.1%) | $33.68 M(+1.3%) |
| Jun 2024 | - | $1.01 M(-91.0%) | $33.25 M(-6.3%) |
| Mar 2024 | - | $11.25 M(+8.0%) | $35.47 M(+146.9%) |
| Dec 2023 | $14.37 M(-162.9%) | $10.41 M(-1.7%) | $14.37 M(+23.4%) |
| Sep 2023 | - | $10.59 M(+228.0%) | $11.64 M(-36.4%) |
| Jun 2023 | - | $3.23 M(-132.7%) | $18.31 M(+1412.2%) |
| Mar 2023 | - | -$9.86 M(-228.3%) | $1.21 M(-107.7%) |
| Dec 2022 | -$22.83 M(-210.5%) | $7.68 M(-55.5%) | -$15.83 M(-45.3%) |
| Sep 2022 | - | $17.26 M(-224.4%) | -$28.95 M(-18.9%) |
| Jun 2022 | - | -$13.87 M(-48.4%) | -$35.71 M(+63.0%) |
| Mar 2022 | - | -$26.89 M(+394.8%) | -$21.91 M(-206.1%) |
| Dec 2021 | $20.65 M(-322.7%) | -$5.43 M(-151.8%) | $20.65 M(+1.1%) |
| Sep 2021 | - | $10.50 M(<-9900.0%) | $20.43 M(+75.5%) |
| Jun 2021 | - | -$74.00 K(-100.5%) | $11.64 M(-35.1%) |
| Mar 2021 | - | $15.66 M(-376.8%) | $17.93 M(-293.3%) |
| Dec 2020 | -$9.27 M(-142.0%) | -$5.66 M(-431.1%) | -$9.27 M(+352.6%) |
| Sep 2020 | - | $1.71 M(-72.5%) | -$2.05 M(-81.5%) |
| Jun 2020 | - | $6.22 M(-153.9%) | -$11.06 M(-141.0%) |
| Mar 2020 | - | -$11.54 M(-836.9%) | $26.97 M(+20.5%) |
| Dec 2019 | $22.07 M(-189.3%) | $1.57 M(-121.4%) | $22.38 M(-19.5%) |
| Sep 2019 | - | -$7.31 M(-116.5%) | $27.80 M(+0.9%) |
| Jun 2019 | - | $44.25 M(-374.3%) | $27.54 M(-179.7%) |
| Mar 2019 | - | -$16.13 M(-330.8%) | -$34.55 M(+39.8%) |
| Dec 2018 | -$24.71 M(-88.9%) | $6.99 M(-192.3%) | -$24.71 M(-79.0%) |
| Sep 2018 | - | -$7.57 M(-57.6%) | -$117.46 M(-28.8%) |
| Jun 2018 | - | -$17.84 M(+183.5%) | -$164.95 M(-14.5%) |
| Mar 2018 | - | -$6.29 M(-92.7%) | -$193.03 M(-13.4%) |
| Dec 2017 | -$222.90 M(+49.6%) | -$85.75 M(+55.7%) | -$222.90 M(+24.8%) |
| Sep 2017 | - | -$55.06 M(+19.9%) | -$178.66 M(+12.7%) |
| Jun 2017 | - | -$45.92 M(+27.0%) | -$158.56 M(+5.7%) |
| Mar 2017 | - | -$36.17 M(-12.9%) | -$150.07 M(+0.7%) |
| Dec 2016 | -$148.97 M | -$41.52 M(+18.8%) | -$148.97 M(+6.0%) |
| Sep 2016 | - | -$34.96 M(-6.6%) | -$140.55 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | -$37.43 M(+6.7%) | -$142.61 M(+1.8%) |
| Mar 2016 | - | -$35.07 M(+6.0%) | -$140.08 M(-10.0%) |
| Dec 2015 | -$155.65 M(+98.3%) | -$33.09 M(-10.6%) | -$155.65 M(+9.9%) |
| Sep 2015 | - | -$37.02 M(+6.1%) | -$141.65 M(+9.7%) |
| Jun 2015 | - | -$34.90 M(-31.1%) | -$129.08 M(+15.4%) |
| Mar 2015 | - | -$50.64 M(+165.3%) | -$111.87 M(+42.5%) |
| Dec 2014 | -$78.50 M(+41.0%) | -$19.09 M(-21.9%) | -$78.50 M(+7.3%) |
| Sep 2014 | - | -$24.45 M(+38.2%) | -$73.17 M(+20.3%) |
| Jun 2014 | - | -$17.69 M(+2.5%) | -$60.82 M(+12.1%) |
| Mar 2014 | - | -$17.27 M(+25.4%) | -$54.28 M(-2.5%) |
| Dec 2013 | -$55.68 M(+23.5%) | -$13.77 M(+13.8%) | -$55.68 M(-17.0%) |
| Sep 2013 | - | -$12.09 M(+8.5%) | -$67.11 M(+7.1%) |
| Jun 2013 | - | -$11.15 M(-40.3%) | -$62.66 M(+3.5%) |
| Mar 2013 | - | -$18.66 M(-25.9%) | -$60.53 M(+34.3%) |
| Dec 2012 | -$45.07 M(+1690.8%) | -$25.20 M(+229.3%) | -$45.07 M(+103.0%) |
| Sep 2012 | - | -$7.65 M(-15.1%) | -$22.21 M(+51.1%) |
| Jun 2012 | - | -$9.02 M(+181.0%) | -$14.70 M(+156.9%) |
| Mar 2012 | - | -$3.21 M(+37.7%) | -$5.72 M(+127.3%) |
| Dec 2011 | -$2.52 M(>+9900.0%) | -$2.33 M(+1527.4%) | -$2.52 M(+1291.4%) |
| Sep 2011 | - | -$143.20 K(+263.5%) | -$180.90 K(+342.3%) |
| Jun 2011 | - | -$39.40 K(+910.3%) | -$40.90 K(+948.7%) |
| Mar 2011 | - | -$3900.00(-169.6%) | -$3900.00(-44.3%) |
| Dec 2010 | -$7000.00(-58.3%) | $5600.00(-275.0%) | -$7000.00(-48.5%) |
| Sep 2010 | - | -$3200.00(+33.3%) | -$13.60 K(-15.0%) |
| Jun 2010 | - | -$2400.00(-65.7%) | -$16.00 K(0.0%) |
| Mar 2010 | - | -$7000.00(+600.0%) | -$16.00 K(-4.8%) |
| Dec 2009 | -$16.80 K(+42.4%) | -$1000.00(-82.1%) | -$16.80 K(-6.7%) |
| Sep 2009 | - | -$5600.00(+133.3%) | -$18.00 K(+23.3%) |
| Jun 2009 | - | -$2400.00(-69.2%) | -$14.60 K(-3.3%) |
| Mar 2009 | - | -$7800.00(+254.5%) | -$15.10 K(+28.0%) |
| Dec 2008 | -$11.80 K | -$2200.00(0.0%) | -$11.80 K(+22.9%) |
| Sep 2008 | - | -$2200.00(-24.1%) | -$9600.00(+29.7%) |
| Jun 2008 | - | -$2900.00(-35.6%) | -$7400.00(+64.4%) |
| Mar 2008 | - | -$4500.00 | -$4500.00 |
FAQ
- What is Puma Biotechnology annual free cash flow?
- What is the all time high annual FCF for Puma Biotechnology?
- What is Puma Biotechnology annual FCF year-on-year change?
- What is Puma Biotechnology quarterly free cash flow?
- What is the all time high quarterly FCF for Puma Biotechnology?
- What is Puma Biotechnology quarterly FCF year-on-year change?
- What is Puma Biotechnology TTM free cash flow?
- What is the all time high TTM FCF for Puma Biotechnology?
- What is Puma Biotechnology TTM FCF year-on-year change?
What is Puma Biotechnology annual free cash flow?
The current annual FCF of PBYI is $14.37 M
What is the all time high annual FCF for Puma Biotechnology?
Puma Biotechnology all-time high annual free cash flow is $22.07 M
What is Puma Biotechnology annual FCF year-on-year change?
Over the past year, PBYI annual free cash flow has changed by +$37.20 M (+162.95%)
What is Puma Biotechnology quarterly free cash flow?
The current quarterly FCF of PBYI is $11.02 M
What is the all time high quarterly FCF for Puma Biotechnology?
Puma Biotechnology all-time high quarterly free cash flow is $44.25 M
What is Puma Biotechnology quarterly FCF year-on-year change?
Over the past year, PBYI quarterly free cash flow has changed by +$430.00 K (+4.06%)
What is Puma Biotechnology TTM free cash flow?
The current TTM FCF of PBYI is $33.68 M
What is the all time high TTM FCF for Puma Biotechnology?
Puma Biotechnology all-time high TTM free cash flow is $35.47 M
What is Puma Biotechnology TTM FCF year-on-year change?
Over the past year, PBYI TTM free cash flow has changed by +$22.04 M (+189.31%)